e-learning
resources
London 2016
Tuesday, 06.09.2016
Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Leucocytes platelets co-aggregates remain elevated in patients with perfusion defects after pulmonary embolism
Anne Roche (Paris, France), Anne Roche, Nicolas Gendron, Vanessa Grangier, Luc De Chaisemartin, Benjamin Planquette, Pascale Gaussem, David Smadja, Olivier Sanchez
Source:
International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session:
Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session type:
Poster Discussion
Number:
3600
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anne Roche (Paris, France), Anne Roche, Nicolas Gendron, Vanessa Grangier, Luc De Chaisemartin, Benjamin Planquette, Pascale Gaussem, David Smadja, Olivier Sanchez. Leucocytes platelets co-aggregates remain elevated in patients with perfusion defects after pulmonary embolism. Eur Respir J 2016; 48: Suppl. 60, 3600
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Related content which might interest you:
Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Evolution of pulmonary blood volume under anticoagulant therapy after a first symptomatic pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Do persistent perfusion defects predict late recurrences in pulmonary embolism?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
From CTPA-proven pulmonary embolism to patients clinical characteristics
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Treprostinil prodrugs for pulmonary arterial hypertension evaluated in cAMP profiling studies in live CHO-K1 cells
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Changes in red blood cell membrane structure in pulmonary arterial hypertension
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016
Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Obligatory role of MEK/ERK/RSK90 in the mitogenic responses of human pulmonary artery smooth muscle cells
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Pulmonary fibroblasts are affected by notch ligands in vitro
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept